Research on the modulation of the NLRP3 inflammasome via diet and fatty acid-induced obesity will open new avenues for treating or relieving complications in metabolic inflammatory disorders. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.